Atara Biotherapeutics Files 8-K: Operations & Financial Update
Ticker: ATRA · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1604464
| Field | Detail |
|---|---|
| Company | Atara Biotherapeutics, INC. (ATRA) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition, filing
Related Tickers: ATRA
TL;DR
ATRA filed an 8-K on July 14, 2025, covering operations, financials, and exhibits.
AI Summary
On July 14, 2025, Atara Biotherapeutics, Inc. filed an 8-K report. The filing primarily concerns results of operations, financial condition, and other events. It also includes financial statements and exhibits, providing an update on the company's status.
Why It Matters
This 8-K filing provides crucial updates on Atara Biotherapeutics' operational and financial performance, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting operational and financial information, not indicating any immediate significant risks.
Key Players & Entities
- Atara Biotherapeutics, Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-36548 (identifier) — Commission File Number
- 46-0920988 (identifier) — IRS Employer Identification No.
- (805) 623-4211 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing by Atara Biotherapeutics?
The primary purpose of this 8-K filing is to report on the company's results of operations and financial condition, as well as other events and financial statements and exhibits.
On what date was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 14, 2025.
In which U.S. state is Atara Biotherapeutics, Inc. incorporated?
Atara Biotherapeutics, Inc. is incorporated in Delaware.
What is the Commission File Number for Atara Biotherapeutics, Inc.?
The Commission File Number for Atara Biotherapeutics, Inc. is 001-36548.
What is the business address of Atara Biotherapeutics, Inc.?
The business address of Atara Biotherapeutics, Inc. is 2380 Conejo Spectrum Street, Suite 200, Thousand Oaks, California, 91320.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Atara Biotherapeutics, Inc. (ATRA).